XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Retained earnings
Treasury stock
Accumulated other comprehensive (loss) income
Beginning balance (in shares) at Dec. 31, 2020   4,480,100        
Beginning balances at Dec. 31, 2020 $ 80,867 $ 9,910 $ 1,393 $ 71,097 $ (4,169) $ 2,636
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 5,867     5,867    
Other comprehensive income (loss) (1,635)         (1,635)
Dividend reinvestment plan (in shares)   718        
Dividend reinvestment plan 21   15   6  
Cash dividends declared (2,958)     (2,958)    
Stock based compensation expense (in shares)   2,152        
Stock based compensation expense 183 $ 4 179      
Exercise of stock options (in shares)   1,000        
Exercise of stock options 24 $ 2 22      
Purchase of treasury stock (in shares)   (97)        
Purchase of treasury stock (2)       (2)  
Ending balance (in shares) at Jun. 30, 2021   4,483,873        
Ending balances at Jun. 30, 2021 82,367 $ 9,916 1,609 74,006 (4,165) 1,001
Beginning balance (in shares) at Mar. 31, 2021   4,480,954        
Beginning balances at Mar. 31, 2021 79,823 $ 9,911 1,504 72,494 (4,167) 81
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 2,991     2,991    
Other comprehensive income (loss) 920         920
Dividend reinvestment plan (in shares)   267        
Dividend reinvestment plan 9   7   2  
Cash dividends declared (1,479)     (1,479)    
Stock based compensation expense (in shares)   2,152        
Stock based compensation expense 91 $ 4 87      
Exercise of stock options (in shares)   500        
Exercise of stock options 12 $ 1 11      
Ending balance (in shares) at Jun. 30, 2021   4,483,873        
Ending balances at Jun. 30, 2021 82,367 $ 9,916 1,609 74,006 (4,165) 1,001
Beginning balance (in shares) at Dec. 31, 2021   4,493,655        
Beginning balances at Dec. 31, 2021 84,341 $ 9,934 1,769 78,350 (4,160) (1,552)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 5,413     5,413    
Other comprehensive income (loss) (26,847)         (26,847)
Dividend reinvestment plan (in shares)   928        
Dividend reinvestment plan 28   20   8  
Cash dividends declared (3,146)     (3,146)    
Stock based compensation expense (in shares)   2,879        
Stock based compensation expense 236 $ 6 230      
Purchase of treasury stock (in shares)   (2,650)        
Purchase of treasury stock (79)       (79)  
Ending balance (in shares) at Jun. 30, 2022   4,494,812        
Ending balances at Jun. 30, 2022 59,946 $ 9,940 2,019 80,617 (4,231) (28,399)
Beginning balance (in shares) at Mar. 31, 2022   4,493,170        
Beginning balances at Mar. 31, 2022 69,417 $ 9,937 1,878 79,259 (4,231) (17,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 2,931     2,931    
Other comprehensive income (loss) (10,973)         (10,973)
Dividend reinvestment plan (in shares)   512        
Dividend reinvestment plan 15   11   4  
Cash dividends declared (1,573)     (1,573)    
Stock based compensation expense (in shares)   1,280        
Stock based compensation expense 133 $ 3 130      
Purchase of treasury stock (in shares)   (150)        
Purchase of treasury stock (4)       (4)  
Ending balance (in shares) at Jun. 30, 2022   4,494,812        
Ending balances at Jun. 30, 2022 $ 59,946 $ 9,940 $ 2,019 $ 80,617 $ (4,231) $ (28,399)